[PDF][PDF] Type I interferon signaling disrupts the hepatic urea cycle and alters systemic metabolism to suppress T cell function

…, A Orlova, N Pikor, D Reil, M Ozsvar-Kozma… - Immunity, 2019 - cell.com
Infections induce complex host responses linked to antiviral defense, inflammation, and
tissue damage and repair. We hypothesized that the liver, as a central metabolic hub, may …

[PDF][PDF] Sialic acid-binding immunoglobulin-like lectin G promotes atherosclerosis and liver inflammation by suppressing the protective functions of B-1 cells

S Gruber, T Hendrikx, D Tsiantoulas, M Ozsvar-Kozma… - Cell reports, 2016 - cell.com
Atherosclerosis is initiated and sustained by hypercholesterolemia, which results in the
generation of oxidized LDL (OxLDL) and other metabolic byproducts that trigger inflammation. …

B cell–activating factor neutralization aggravates atherosclerosis

D Tsiantoulas, AP Sage, L Göderle, M Ozsvar-Kozma… - Circulation, 2018 - Am Heart Assoc
Background: Atherosclerotic cardiovascular disease (heart attacks and strokes) is the major
cause of death globally and is caused by the buildup of a plaque in the arterial wall. …

Increased plasma IgE accelerate atherosclerosis in secreted IgM deficiency

D Tsiantoulas, I Bot, M Ozsvar-Kozma… - Circulation …, 2017 - Am Heart Assoc
Rationale: Deficiency of secreted IgM (sIgM −/− ) accelerates atherosclerosis in Ldlr −/− mice.
Several atheroprotective effects of increased levels of IgM antibodies have been suggested…

APRIL limits atherosclerosis by binding to heparan sulfate proteoglycans

…, F Frommlet, A Mueller, T Hendrikx, M Ozsvar-Kozma… - Nature, 2021 - nature.com
Atherosclerotic cardiovascular disease causes heart attacks and strokes, which are the
leading causes of mortality worldwide 1 . The formation of atherosclerotic plaques is initiated …

Cell-autonomous regulation of complement C3 by factor H limits macrophage efferocytosis and exacerbates atherosclerosis

…, HQ Dinh, MS Narzt, L Göderle, M Ozsvár-Kozma… - Immunity, 2023 - cell.com
Complement factor H (CFH) negatively regulates consumption of complement component 3
(C3), thereby restricting complement activation. Genetic variants in CFH predispose to …

[HTML][HTML] Monocyte subset distribution in patients with stable atherosclerosis and elevated levels of lipoprotein (a)

…, A Wonnerth, G Goliasch, M Ozsvar-Kozma… - Journal of clinical …, 2015 - Elsevier
Background Lipoprotein(a) (Lp(a)) is a proatherogenic plasma lipoprotein currently established
as an independent risk factor for the development of atherosclerotic disease and as a …

A genome-wide association study identifies key modulators of complement factor H binding to malondialdehyde-epitopes

…, RB Rudnick, M Ozsvar-Kozma… - Proceedings of the …, 2020 - National Acad Sciences
Genetic variants within complement factor H (CFH), a major alternative complement pathway
regulator, are associated with the development of age-related macular degeneration (AMD) …

[HTML][HTML] High immunoglobulin-M levels to oxidation-specific epitopes are associated with lower risk of acute myocardial infarction

A Taleb, P Willeit, S Amir, T Perkmann, MO Kozma… - Journal of lipid …, 2023 - ASBMB
Immunoglobulin M (IgM) autoantibodies to oxidation-specific epitopes (OSEs) can be present
at birth and protect against atherosclerosis in experimental models. This study sought to …

Impaired Autophagy in CD11b+ Dendritic Cells Expands CD4+ Regulatory T Cells and Limits Atherosclerosis in Mice

…, S Saveljeva, MKL Ma, M Ozsvar-Kozma… - Circulation …, 2019 - Am Heart Assoc
Rationale: Atherosclerosis is a chronic inflammatory disease. Recent studies have shown
that dysfunctional autophagy in endothelial cells, smooth muscle cells, and macrophages, …